Literature DB >> 12902323

Roles of His291-alpha and His146-beta' in the reductive acylation reaction catalyzed by human branched-chain alpha-ketoacid dehydrogenase: refined phosphorylation loop structure in the active site.

R Max Wynn1, Mischa Machius, Jacinta L Chuang, Jun Li, Diana R Tomchick, David T Chuang.   

Abstract

We report here that alterations of either His291-alpha or His146-beta' in the active site of human branched-chain alpha-ketoacid dehydrogenase (E1b) impede both the decarboxylation and the reductive acylation reactions catalyzed by E1b as well as the binding of cofactor thiamin diphosphate (ThDP). In a refined human E1b active-site structure, His291-alpha, which aligns with His407 in Escherichia coli pyruvate dehydrogenase and His263 in yeast transketolase, is on a largely ordered phosphorylation loop. The imidazole ring of His291-alpha in E1b coordinates to the terminal phosphate oxygen atoms of bound ThDP. The N3 atom of wild-type His146-beta', which can be protonated, binds a water molecule and points toward the aminopyrimidine ring of ThDP. Remarkably, the H291A-alpha mutation results in a complete order-to-disorder transition of the loop region, which precludes the binding of the substrate lipoyl-bearing domain to E1b. The H146A-beta' mutation, on the other hand, does not alter the loop structure, but nullifies the reductive acylation activity of E1b. Our results suggest that: 1) His291-alpha plays a structural rather than a catalytic role in the binding of cofactor ThDP and the lipoyl-bearing domain to E1b, and 2) His146-beta' is an essential catalytic residue, probably functioning as a proton donor in the reductive acylation of lipoamide on the lipoyl-bearing domain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902323     DOI: 10.1074/jbc.M306204200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Crystal structure and interaction studies of human DHTKD1 provide insight into a mitochondrial megacomplex in lysine catabolism.

Authors:  Gustavo A Bezerra; William R Foster; Henry J Bailey; Kevin G Hicks; Sven W Sauer; Bianca Dimitrov; Thomas J McCorvie; Jürgen G Okun; Jared Rutter; Stefan Kölker; Wyatt W Yue
Journal:  IUCrJ       Date:  2020-06-10       Impact factor: 4.769

2.  Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock.

Authors:  Zsolt Bikadi; Eszter Hazai
Journal:  J Cheminform       Date:  2009-09-11       Impact factor: 5.514

3.  Structural basis for inactivation of the human pyruvate dehydrogenase complex by phosphorylation: role of disordered phosphorylation loops.

Authors:  Masato Kato; R Max Wynn; Jacinta L Chuang; Shih-Chia Tso; Mischa Machius; Jun Li; David T Chuang
Journal:  Structure       Date:  2008-12-10       Impact factor: 5.006

4.  Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease.

Authors:  Yi Guo; Liu Liming; Li Jiang
Journal:  Metab Brain Dis       Date:  2015-08-04       Impact factor: 3.584

5.  Asp295 stabilizes the active-site loop structure of pyruvate dehydrogenase, facilitating phosphorylation of ser292 by pyruvate dehydrogenase-kinase.

Authors:  Tripty A Hirani; Alejandro Tovar-Méndez; Ján A Miernyk; Douglas D Randall
Journal:  Enzyme Res       Date:  2011-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.